Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Hematology/Oncology Clinics of North America
|
March 31, 2009
Bone marrow failure syndromes. Preface
Grover C Bagby, Gabrielle Meyers
Hematology. American Society of Hematology. Education Program
|
November 21, 2007
Bone marrow failure as a risk factor for clonal evolution: prospects for leukemia prevention
Grover C Bagby, Gabrielle Meyers
International Journal of Hematology
|
March 12, 2003
Management issues in paroxysmal nocturnal hemoglobinuria
Gabrielle Meyers, Charles J Parker
Hematology/Oncology Clinics of North America
|
March 31, 2009
Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention
Grover C Bagby, Gabrielle Meyers
Current Problems in Cancer
|
October 21, 2023
Frailty and Preoperative Palliative Care in Surgical Oncology
Zoe Tao, Elizabeth Hays, Gabrielle Meyers, et al.
Journal of Geriatric Oncology
|
January 20, 2026
Graft versus host disease treatment and prevention in older adults: A single-database review
William Ciurylo, Anahid Hamparsumian, Sarah Wall, et al.
Bone Marrow Transplantation
|
February 21, 2018
A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT)
Joseph Bubalo, Kelsey Mulverhill, Gabrielle Meyers, et al.
Seminars in Hematology
|
January 28, 2009
The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients
Neal S Young, Gabrielle Meyers, Hubert Schrezenmeier, et al.
Leukemia & Lymphoma
|
May 7, 2019
Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy
Curtis Lachowiez, Matthew Kearney, Gabrielle Meyers, et al.
Dermatology (Basel, Switzerland)
|
May 29, 2024
Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients with Hematologic Malignancies: A Single Institution Experience
Mallory deCampos-Stairiker, Shannon Kody, Gabrielle Meyers, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Hematology/Oncology Clinics of North America
|
March 31, 2009
Bone marrow failure syndromes. Preface
Grover C Bagby, Gabrielle Meyers
Hematology. American Society of Hematology. Education Program
|
November 21, 2007
Bone marrow failure as a risk factor for clonal evolution: prospects for leukemia prevention
Grover C Bagby, Gabrielle Meyers
International Journal of Hematology
|
March 12, 2003
Management issues in paroxysmal nocturnal hemoglobinuria
Gabrielle Meyers, Charles J Parker
Hematology/Oncology Clinics of North America
|
March 31, 2009
Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention
Grover C Bagby, Gabrielle Meyers
Current Problems in Cancer
|
October 21, 2023
Frailty and Preoperative Palliative Care in Surgical Oncology
Zoe Tao, Elizabeth Hays, Gabrielle Meyers, et al.
Journal of Geriatric Oncology
|
January 20, 2026
Graft versus host disease treatment and prevention in older adults: A single-database review
William Ciurylo, Anahid Hamparsumian, Sarah Wall, et al.
Bone Marrow Transplantation
|
February 21, 2018
A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT)
Joseph Bubalo, Kelsey Mulverhill, Gabrielle Meyers, et al.
Seminars in Hematology
|
January 28, 2009
The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients
Neal S Young, Gabrielle Meyers, Hubert Schrezenmeier, et al.
Leukemia & Lymphoma
|
May 7, 2019
Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy
Curtis Lachowiez, Matthew Kearney, Gabrielle Meyers, et al.
Dermatology (Basel, Switzerland)
|
May 29, 2024
Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients with Hematologic Malignancies: A Single Institution Experience
Mallory deCampos-Stairiker, Shannon Kody, Gabrielle Meyers, et al.
Page
of 5